Skip to main content

Advertisement

Log in

Clinical significance of kinesin family member 2A as a facilitating biomarker of disease surveillance and prognostication in cervical cancer patients

  • Original Article
  • Published:
Irish Journal of Medical Science (1971 -) Aims and scope Submit manuscript

Abstract

Background

Cervical cancer is one of the most common and fatal malignancies among females, and biomarkers are essential for assisting in its management. Kinesin family member 2A (KIF2A) has been exhibited to be a potential maker in various cancers; however, its role in cervical cancer has yet to be reported. Therefore, we aimed to assess the expression of KIF2A and its correlation with clinicopathological characteristics as well as survival profile in cervical cancer patients.

Methods

A hundred and thirty-five cervical cancer patients who underwent simple trachelectomy or radical hysterectomy were retrospectively analyzed. Tumor tissues and paired adjacent tissues were acquired, in which KIF2A mRNA and protein expressions were determined by reverse transcription quantitative polymerase chain reaction and immunohistochemistry assay, respectively. Disease-free survival (DFS) and overall survival (OS) were documented with a median follow-up duration of 28.0 months.

Results

KIF2A protein (P < 0.001) and mRNA (P < 0.001) expressions were both upregulated in tumor tissues compared to paired adjacent tissues in cervical cancer patients. In addition, tumor tissue KIF2A protein and mRNA expressions were positively associated with lymph node metastasis (P = 0.025 and P = 0.010, respectively) and FIGO stage (P = 0.022 and P = 0.015, respectively) in cervical cancer patients. Moreover, patients with tumor tissue KIF2A high expression (mRNA and protein) displayed worse DFS (P = 0.010 and P = 0.046, respectively) and OS (P = 0.042 and P = 0.030, respectively) compared to patients with tumor tissue KIF2A low expression (mRNA and protein).

Conclusion

Tumor tissue KIF2A expression could serve as a biomarker enhancing the disease surveillance and prognostication in cervical cancer management.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Siegel RL, Miller KD, Jemal A (2018) Cancer statistics, 2018. CA Cancer J Clin 68(1):7–30. https://doi.org/10.3322/caac.21442

    Article  PubMed  Google Scholar 

  2. Minion LE, Tewari KS (2018) Cervical cancer - state of the science: from angiogenesis blockade to checkpoint inhibition. Gynecol Oncol 148(3):609–621. https://doi.org/10.1016/j.ygyno.2018.01.009

    Article  PubMed  PubMed Central  Google Scholar 

  3. Li H, Wu X, Cheng X (2016) Advances in diagnosis and treatment of metastatic cervical cancer. J Gynecol Oncol 27(4):e43. https://doi.org/10.3802/jgo.2016.27.e43

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Noda Y, Niwa S, Homma N et al (2012) Phosphatidylinositol 4-phosphate 5-kinase alpha (PIPKalpha) regulates neuronal microtubule depolymerase kinesin, KIF2A and suppresses elongation of axon branches. Proc Natl Acad Sci U S A 109(5):1725–1730. https://doi.org/10.1073/pnas.1107808109

    Article  PubMed  PubMed Central  Google Scholar 

  5. Parrini E, Conti V, Dobyns WB, Guerrini R (2016) Genetic basis of brain malformations. Mol Syndromol 7(4):220–233. https://doi.org/10.1159/000448639

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Xie T, Li X, Ye F et al (2018) High KIF2A expression promotes proliferation, migration and predicts poor prognosis in lung adenocarcinoma. Biochem Biophys Res Commun 497(1):65–72. https://doi.org/10.1016/j.bbrc.2018.02.020

    Article  CAS  PubMed  Google Scholar 

  7. Sheng N, Xu YZ, Xi QH et al (2018) Overexpression of KIF2A is suppressed by miR-206 and associated with poor prognosis in ovarian cancer. Cell Physiol Biochem 50(3):810–822. https://doi.org/10.1159/000494467

    Article  CAS  PubMed  Google Scholar 

  8. Zhang Y, You X, Liu H et al (2017) High KIF2A expression predicts unfavorable prognosis in diffuse large B cell lymphoma. Ann Hematol 96(9):1485–1491. https://doi.org/10.1007/s00277-017-3047-1

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Colombo N, Carinelli S, Colombo A et al (2012) Cervical cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 23(Suppl 7):vii27–vii32. https://doi.org/10.1093/annonc/mds268

    Article  PubMed  Google Scholar 

  10. Hu Z, Gu X, Zhong R et al (2018) Tumor-infiltrating CD45RO(+) memory cells correlate with favorable prognosis in patients with lung adenocarcinoma. J Thorac Dis 10(4):2089–2099. https://doi.org/10.21037/jtd.2018.03.148

    Article  PubMed  PubMed Central  Google Scholar 

  11. Tian Y, Zhao K, Yuan L et al (2018) EIF3B correlates with advanced disease stages and poor prognosis, and it promotes proliferation and inhibits apoptosis in non-small cell lung cancer. Cancer Biomark 23(2):291–300. https://doi.org/10.3233/CBM-181628

    Article  CAS  PubMed  Google Scholar 

  12. Wang D, Zhu H, Ye Q et al (2016) Prognostic value of KIF2A and HER2-Neu overexpression in patients with epithelial ovarian cancer. Medicine (Baltimore) 95(8):e2803. https://doi.org/10.1097/MD.0000000000002803

    Article  CAS  Google Scholar 

  13. Zhao P, Lan F, Zhang H et al (2018) Down-regulation of KIF2A inhibits gastric cancer cell invasion via suppressing MT1-MMP. Clin Exp Pharmacol Physiol 45(10):1010–1018. https://doi.org/10.1111/1440-1681.12974

    Article  CAS  PubMed  Google Scholar 

  14. Zhang Q, Lu D, Liu W et al (2019) Effects of KIF2A on the prognosis of nasopharyngeal carcinoma and nasopharyngeal carcinoma cells. Oncol Lett 18(3):2718–2723. https://doi.org/10.3892/ol.2019.10597

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Zhang S, Huang F, Wang Y et al (2016) KIF2A overexpression and its association with clinicopathologic characteristics and poor prognoses in patients with gastric cancer. Dis Markers 2016:7484516–7484519. https://doi.org/10.1155/2016/7484516

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Wang ZX, Ren SC, Chang ZS, Ren J (2020) Identification of kinesin family member 2A (KIF2A) as a promising therapeutic target for osteosarcoma. Biomed Res Int 2020:7102757–7102759. https://doi.org/10.1155/2020/7102757

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Xiaoji Hu.

Ethics declarations

Ethics approval and consent to participate

The current study was approved by the Institutional Review Board. Patients or their guardians provided the written informed consents.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lei, G., Xin, X. & Hu, X. Clinical significance of kinesin family member 2A as a facilitating biomarker of disease surveillance and prognostication in cervical cancer patients. Ir J Med Sci 191, 665–670 (2022). https://doi.org/10.1007/s11845-021-02510-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11845-021-02510-9

Keywords

Navigation